05-15 AUA 2026: Phase II ARASEC Data Further Supports the Efficacy and Safety of NUBEQA® (darolutamide) Plus ADT in Patients with Metastatic Castration-Sensitive Prostate Cancer BU
05-15 Bayer Introduces Midol® in Motion, Empowering Menstruators to Find PMS Relief Through Movement BU
05-15 BMO Revises Estimates for Bayer Post-Q1 Results; Market Perform Rating Kept MT
05-14 Bayer Kept at Buy as Mwb Notes 'Solid' Q1 Results MT
05-14 BAYER AG : JP Morgan maintains a Buy rating ZD
05-13 Bayer Partners with Luke Bryan to Donate 1 Million Meals Through Feeding America® to Expand Access to Food and Nutrition in Rural Communities BU
05-13 BAYER AG : Deutsche Bank sticks Neutral ZD
05-13 BAYER AG : UBS gives a Buy rating ZD
05-13 Bayer Kept at Market Perform as BMO Notes One-time Seed Licensing Boost in Q1 MT
05-12 Bayer: An assuring quarter towards gradual transformation Alphavalue
05-12 Bayer Aktiengesellschaft, Q1 2026 Earnings Call, May 12, 2026
05-12 Bayer surprises with robust agricultural performance as Glyphosate ruling looms RE
05-12 Bayer Shares Climb After Earnings Beat Expectations DJ
05-12 Bayer Aktiengesellschaft, Q1 2026 Earnings Call, May 12, 2026
05-12 Pharma and CropScience divisions drive Bayer recovery DP
05-12 BAYER AG : Gets a Buy rating from Barclays ZD
05-12 Bayer CEO remains confident in glyphosate dispute, awaits Supreme Court ruling RE
05-12 BAYER AG : JP Morgan remains its Buy rating ZD
05-12 JPMorgan maintains 'Overweight' rating on Bayer - Target 50 euros DP
05-12 Bayer : Q1 Media Update PU
05-12 Bayer surprises to the upside on agricultural strength - shares rally sharply DP
05-12 Germany's Bayer Logs Higher Q1 Net Income; Net Sales Down MT
05-12 Bayer Reiterates 2026 Currency-adjusted Outlook as First-quarter Profit More Than Doubles MT
05-12 Strong Agribusiness Performance Delivers Surprise Earnings Jump for Bayer RE
05-12 Bayer : First Quarter 2026 Results and Media Update PU
No results for this search